Company: CDT
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641172-25-024140
Chunk: 113

Company: CDT Equity Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 8
Chunk 113
---
 The Company received proceeds of $11.9 million, net of commissions payable to A.G.P. of $0.4 million.
As of the date of this Quarterly Report on Form 10-Q, the Company has approximately $8.0 million available under the Sales Agreement.

    23

Share
Repurchase Program

On
April 10, 2025, the Company’s Board of Directors authorized a share repurchase program under which the Company may purchase up
to $1.0 million of its outstanding Common Stock. Under the program, CDT may repurchase shares from time to time through open market
transactions or other methods in compliance with SEC Rule 10b-18. Purchases will be executed by The Benchmark Company, the Company’s
appointed broker, and will be subject to market conditions, corporate liquidity requirements, regulatory considerations, and other factors.
As of June 30, 2025, the Company has repurchased an aggregate of 11,713 shares of its outstanding Common Stock at an average price of
$8.85/share and paid approximately $2,000 in commission to the broker. The repurchased shares are recorded as treasury stock within
the condensed consolidated balance sheets.

10.
Net Loss Per Share Attributable to Common Stockholders

Potentially
dilutive securities (upon conversion) that were not included in the diluted per share calculations because they would have been anti-dilutive
were as follows:

Schedule
of Potentially Dilutive Securities

    As of June 30,  
    As of June 30, 

    2025  
    2024 
  
    Public warrants 
     9,319  
     9,319 
  
    PIPE Warrants 
     -  
     1,333 
  
    A.G.P. Warrants 
     36  
     36 
  
    Convertible Promissory Notes Payable 
     -  
     54 
  
    Stock Options 
     4,030  
     714 
  
    A.G.P. Convertible Note 
     144,016  
     - 
  
    March 2024 Warrants 
     173  
     173 
  
    April 2024 Warrants 
     965  
     965 
  
    A.G.P. 2024 Warrants 
     1,908  
     - 
  
    Antidilutive Securities